AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Immunovant, Inc. Director's Dealing 2019

May 10, 2019

31436_dirs_2019-05-09_05e4acfd-360d-4e73-acee-187ecb24f1e8.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Health Sciences Acquisitions Corp (HSAC)
CIK: 0001764013
Period of Report: 2019-05-09

Reporting Person: GRANADILLO PEDRO P (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20000	Indirect